Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196518 · ClinicalTrials.gov registry record · NA
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
A NA study of Thyroid Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03196518: Active NA study of Thyroid Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03196518 is a NA study of Thyroid Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 5 participants, below the 282-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196518, a NA study of Thyroid Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to evaluate a new imaging test that may allows the investigators to predict the uptake of radioactive iodine by thyroid cancer faster than the current standard and that does not interfere with the uptake of radioactive iodine used for therapy.
Primary Outcome
Safety Outcome Measures (CTCAE v4) severity of adverse events
Conditions Studied
Interventions
- PROCEDURE PET Imaging
- OTHER 18F-tetrafluoroborate (18F-TFB)
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT03196518 still lists
NCT03196518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 282-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Thyroid Cancer appearing as the primary indexed condition, and to 2 interventions - of which PET Imaging is the first listed.
NCT03196518 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03196518 about?
NCT03196518 is a clinical study titled "Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer". The goal of the study is to evaluate a new imaging test that may allows the investigators to predict the uptake of radioactive iodine by thyroid cancer faster than the current standard and that does not interfere with the uptake of radioactive iodine used for therapy.
What is the current status of trial NCT03196518?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2017-06-16. Estimated completion is 2026-06.
What conditions does trial NCT03196518 study?
This clinical trial studies the following conditions: Thyroid Cancer.
What interventions are being tested in trial NCT03196518?
The interventions under investigation include: PET Imaging (PROCEDURE), 18F-tetrafluoroborate (18F-TFB) (OTHER).
Who is sponsoring clinical trial NCT03196518?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03196518 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03196518's enrollment target sits among peer trials
5 47th of 46 the lowest of 46 other Thyroid Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thyroid Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Hereditary Risk Factors for Thyroid Cancer
RECRUITING · NA
-
Personalized Treatment in Thyroid Disorders
RECRUITING · NA
-
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
RECRUITING · NA
-
Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI